Singapore: RWA tokenization rules, cost and constraints
A route for Asia-facing institutional funds and capital-markets products, not a light-touch retail issuance regime.
Last verified 22 July 2026
Singapore is a credible base for institutional tokenized funds and capital-markets products because the Monetary Authority of Singapore has combined existing financial regulation with live industry work on tokenisation. That does not create a regulatory shortcut. Fund management, offers of collective-investment-scheme interests, custody, AML and investor restrictions still depend on the activity and product.
The practical question is not whether Singapore supports tokenisation. It is which regulated activity your structure performs, who conducts it and where the investors are located. Participation in an innovation project is not product approval.
Singapore fits when: the manager and investor strategy are institutional and Asia-facing, and the project can support the applicable fund-management, offering, custody and AML requirements. It is a poor fit when the plan assumes a fast retail token launch or treats Project Guardian as an approval route.
At a glance
| Legal perimeter | Non-EU |
|---|---|
| Regulator | MAS |
| Governing law | Project Guardian; Guide on Tokenisation of Capital Markets Products |
| Vehicle / instrument | Fund or capital-markets product |
| What is licensed | Fund management; offers of collective-investment-scheme interests; custody |
| Investor geography | Asia-facing institutional |
| Distribution effect | Singapore permissions do not authorise offering into other jurisdictions |
| Binding constraint | Not a light-touch issuance route; MAS innovation projects are not product approval |
| Indicative timeline | 6+ months for fund-management and CIS approvals |
| Last verified | 2026-07-22 |
The timeline reflects what the published record and practice suggest. It is not a processing time any regulator commits to.
Fits when — and what it does not solve
Fits when: An Asia-facing institutional manager, not a retail issuance route.
What this regime does not solve:
- Fund-management, offering, custody and AML obligations, which apply in full
- Permission to offer into other jurisdictions
- Speed — approvals are measured in months, not weeks
Which Singapore activities may be regulated?
The question is never “is tokenisation allowed”. It is which regulated activity your structure performs, and who performs it. For a tokenized fund or capital-markets product, the candidates are:
- Fund management — managing the assets, wherever the vehicle is domiciled.
- Offering fund interests or securities — the offer itself, and to whom it may be made.
- Custody — holding assets or keys for clients.
- Dealing and market infrastructure — where secondary trading or intermediation is involved.
Each is a separate permission with its own requirements, and a structure commonly triggers more than one. Tokenised form does not change which of them applies. Verify the current perimeter against MAS material before relying on any summary, including this one.
Does Project Guardian approve a tokenized product?
No. Project Guardian is an industry initiative in which MAS and financial institutions test tokenisation use cases. It produces findings, pilots and published guidance.
It does not authorise a product, licence a participant, or create a fast track to market. Participation evidences involvement in a study, not regulatory approval of anything you intend to sell. Marketing material that implies otherwise is describing a relationship the initiative does not create — and treating it as an approval route is the most common way this regime is misread.
Tokenized fund distribution from Singapore
Setting up in Singapore and being permitted to sell into a given market are two separate questions, decided by two separate regulators. A Singapore permission governs what you may do in Singapore. Whether you may offer the fund to an investor in the Gulf, the EU or the United States is decided where that investor is.
This is the step most often assumed to follow from domicile. Plan the distribution map alongside the setup, not after it — see Gulf vs Asia fund distribution.
Published cost evidence
1 published figure in our dataset is attributed to this jurisdiction. Each carries its own source, currency, cadence and date. Most public pricing in this market comes from providers selling the service they are pricing — the "Sells this?" column says which. Nothing here is averaged.
| Provider | Component | Range | Cadence | Source date | Sells this? | As published | Source |
|---|---|---|---|---|---|---|---|
| OmiSoft | legal structuring | $30,000–$65,000 | one_time | 2026-07-03 | yes | Singapore MAS $30,000-$65,000 | view |
Read these as evidence of what is claimed, not as a quote. See the full cost index for how components are normalised and where sources contradict each other, and how to make quotes comparable before you ask anyone for a price.
What changed recently
MAS published its guide to tokenising capital-markets products and continues Project Guardian with institutional participants.
Closest comparison
- See this regime beside the other 9 in the comparison matrix.
- Weighing Singapore against a Gulf route? See ADGM for a securities or fund structure.
- Choosing between Gulf and Asian distribution? Read Gulf vs Asia fund distribution.
Related reading
- How a tokenized fund is structured — vehicle, manager, custody and distribution as five separate decisions.
Sources and review
Last verified 22 July 2026 by the RWA Legal Index research desk. Reference material, not legal advice. A regime that changed after that date may no longer match what is above — verify against the regulator's own material, and check any claimed licence against the official register. Collection rules and our commercial relationships are on the methodology page; errors go to corrections.
Get this narrowed to your case
Send the asset class, investor geography and expected distribution route. We will return a short list of regimes with the constraint and official source behind each option — options with constraints, not a recommendation.